---
title: "VisCardia secures funding to support RECOVER-HF trial"
date: "2025-12-03T09:35:54.000Z"
publishedDate: "3 décembre 2025"
summary: "VisCardia has secured US$40 million in growth financing to advance the company’s path toward premarket approval (PMA) for its VisONE synchronised diaphragmatic stimulation (SDS) therapy. The financing will support the execution of the company’s pivotal RECOVER-HF clinical study, and key milestones on the path to PMA."
importance: ""
sourceUrl: "https://cardiovascularnews.com/viscardia-secures-funding-to-support-recover-hf-trial/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-12-03-viscardia-secures-funding-to-support-recover-hf-trial"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Medical-students-1024x768-1.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/viscardia-secures-funding-to-support-recover-hf-trial/"
---

![VisCardia secures funding to support RECOVER-HF trial](http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Medical-students-1024x768-1.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/viscardia-secures-funding-to-support-recover-hf-trial/*

## L’essentiel

VisCardia has secured US$40 million in growth financing to advance the company’s path toward premarket approval (PMA) for its VisONE synchronised diaphragmatic stimulation (SDS) therapy. The financing will support the execution of the company’s pivotal RECOVER-HF clinical study, and key milestones on the path to PMA.

## Lien source

https://cardiovascularnews.com/viscardia-secures-funding-to-support-recover-hf-trial/
